4 cancer drugs in shortage: When drugmakers expect supply to rebound
Published 7/01/26
Becker’s Hospital Review examines the ongoing shortages of four critical chemotherapy drugs and the latest manufacturer timelines for restoring supply. The article references data from Premier showing reduced hospital fill rates for ifosfamide and cisplatin, highlighting the supply challenges prompting some providers to adjust treatment schedules and prioritize patients with the greatest clinical need.
